Funding
CardiaTec, a biotech company focused on decoding the biology behind cardiovascular disease, has announced the successful completion of a $6.5 million seed funding round. This capital injection will enable CardiaTec to enhance its platform and advance its proprietary drug targets into the preclinical phase.
Ampersand, one of Africa’s electric vehicle energy tech companies, has secured additional equity funding, bringing its total raised in the past year to $21.5 million. This strong financial backing highlights growing investor confidence in Ampersand’s mission to electrify Africa’s vast motorcycle market.
DeSci Labs has secured $6.5 million in seed funding to develop the infrastructure for a traceable digital version of the scientific record. Supported by prominent investors, this software engineering startup has reached key R&D milestones to launch DeSci Publish, the first open-source, peer-to-peer platform for scientific publishing.
The Series A funding round, spearheaded by Balderton Capital and joined by existing investors TQ Ventures, Earlybird, and Seedcamp, marks a significant milestone for Tilt, a real-time shopping platform. Founded by former Revolut employees Neil Shah and Abhi Thanendran, Tilt is revolutionising the e-commerce landscape by positioning itself as the premier destination for fashion worldwide.
Workpay, a cloud-based platform designed to streamline HR, payroll, and employee benefits across Africa, has secured $5 million in Series A funding. The round was led by Norrsken22 and included investments from Visa, Y Combinator, Saviu Ventures, Axian, Plug n Play, Verod-Kepple Africa Ventures, and Acadian Ventures, a firm known for backing the next wave of work-related technologies. This new funding comes after Workpay’s successful pre-series A round, which raised $2.7 million earlier in 2023.
Finnish biotech company NADMED has secured €3.5 million in a Series A funding round to support its expansion into the US and other global markets with its innovative technology for measuring nicotinamide adenine dinucleotide (NAD). This technology has the potential to enhance the precision of personalised treatments for a range of diseases.
Edinburgh-based B2B SaaS provider Administrate, specialising in learning and training management software, has successfully raised £3.05 million in a new funding round. The Investment Fund for Scotland, Equity Finance, managed by Maven Capital Partners and delivered by the British Business Bank, contributed £1 million. The round also saw continued backing from existing investors Mercia and Archangels.












